Shuguang Tan

12PUBLICATIONS
44CO-AUTHORS
Tumour immunologyNanotoxicology, health and safetyDiscourse and pragmaticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 09, 2026
TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy.

|Jun 03, 2026
Innovative peptide-loaded hybrid membrane nanovaccine enables precise personalized immunotherapy for HPV-related cervical diseases.

|May 27, 2026
Lactylation of PD-L1 by a lactyltransferase HAT1 dictates its protein stability and tumor immune evasion.

|Jun 05, 2025
An Engineered Soluble Single-Chain TCR Engager for KRAS-G12V Specific Tumor Immunotherapy.

Keke Ma, Jie Wang, Min Jiang

|Jan 28, 2025
T cell immune evasion by SARS-CoV-2 JN.1 escapees targeting two cytotoxic T cell epitope hotspots.

Jinmin Tian, Bingli Shang, Jianing Zhang

|Oct 12, 2023
KRAS G12V neoantigen specific T cell receptor for adoptive T cell therapy against tumors.

Dan Lu, Yuan Chen, Min Jiang

Pageof 2

Frequent Collaborators

6 joint publications

George Fu Gao

3 joint publications

Jianxun Qi

2 joint publications

Sheng Yao

1 joint publications

Yan Chai